局部晚期胸腺瘤微创胸腺切除术与开放胸腺切除术的长期结局比较
该多中心回顾性研究纳入2000年1月至2013年12月韩国胸腺研究协会数据库1239例胸腺切除术患者,比较微创胸腺切除术(MIT)与开放胸腺切除术(OT)的结局。倾向性评分匹配378例Masaoka-Koga I或II期胸腺瘤患者后,MIT组手术时间、住院时间和并发症均显著短于/少于OT组(均P<0.005),10年生存率、无复发生存率和R0切除率两组无显著差异。
要点
- MIT组手术时间、住院时间和并发症均显著优于OT组(均P<0.005)。
- 匹配后10年生存率OT 87.7% vs MIT 85.5%,无显著差异。
- 无复发生存率OT 94.0% vs MIT 86.4%,R0切除率两组均为97.35%(P=0.59)。
核心结论
- 与OT相比,MIT与更短的手术时间、更短的住院时间和更少的并发症相关。
- OT组与MIT组的长期生存率、无复发生存率和完全切除率无显著差异。
- 作者认为这些发现可能有助于医生追踪早期或局部晚期胸腺瘤患者的病情进展并为其设计治疗方案。
研究设计与样本
- 多中心回顾性研究,数据来自韩国胸腺研究协会数据库。
- 收集2000年1月至2013年12月间接受胸腺切除术的1239例患者数据。
- 采用未匹配和倾向性评分匹配数据比较MIT组与OT组的术后结局。
- MIT组455例,OT组784例;倾向性评分匹配Masaoka-Koga I或II期胸腺瘤患者378例。
主要发现
- MIT组手术时间、住院时间和并发症均显著短于/少于OT组(均P<0.005)。
- 倾向性评分匹配数据中,10年生存率OT组87.7% vs MIT组85.5%(II期,平均随访时间OT组12.9年 vs MIT组11.1年),两组无显著差异。
- 无复发生存率OT组94.0% vs MIT组86.4%,两组无显著差异。
- R0切除率OT组和MIT组均为97.35%(P=0.59)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Our goal was to compare the oncological outcomes and efficacy between minimally invasive thymectomy (MIT) and open thymectomy (OT) in patients with early or locally advanced thymoma using a multicentre study database. METHODS: We retrospectively collected data from 1,239 patients who underwent thymectomy between January 2000 and December 2013, as recorded in the database of the Korean Association for Research on Thymus. We compared the postoperative outcomes of the MIT and OT groups using unmatched and propensity score (PS) matched data. RESULTS: We excised the thymoma using MIT and OT in 455 and 784 patients, respectively. We matched 378 patients with Masaoka-Koga stage I or II thymoma by their PS. The operative time, duration of hospital stay and complications were significantly shorter in the MIT group than in the OT group (all P < 0.005). In the PS matched data, the groups did not show significant differences in the 10-year survival rate (87.7% in OT vs 85.5% in MIT, stage II, mean follow-up duration: 12.9 years in OT vs 11.1 years in MIT), recurrence-free survival (94.0% in OT vs 86.4% in MIT) and R0 resection (97.35% in OT and MIT, P = 0.59). CONCLUSIONS: Compared with OT, MIT was associated with shorter operative times, shorter durations of hospital stay and fewer complications. Long-term survival, recurrence-free survival and complete resection were not significantly different between the OT and MIT groups. Our findings may help physicians track the progress of patients with early or locally advanced thymomas and design treatment plans for them.
引用
- Hwang SK, Lee GD, Kang CH, et al. Long-term outcome of minimally invasive thymectomy versus open thymectomy for locally advanced cases. Eur J Cardiothorac Surg. 2022. PMID: 35445251. doi:10.1093/ejcts/ezac238
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。